Europeans are Interested in Online Patient Education Programs

Manhattan ResearchHalf of Europeans using the Internet for health information are interested in online patient education programs from pharmaceutical companies, although just a small fraction are currently using these types of programs, according to Manhattan Research's Cybercitizen Health® Europe v10.0 research. The survey explored the digital media and online health behaviors of 3,000 online adults in France, Germany, Italy, Spain, and the United Kingdom.

This strong demand in online patient education programs represents an opportunity for pharmaceutical companies, especially given the strong limits on direct consumer advertising. Additionally, the population of consumers in France, Germany, Italy, Spain, and the United Kingdom using the Internet for pharmaceutical information has increased considerably in recent years, growing from 54.7 million consumers in 2008 to 75 million consumers in 2010.

Highlights from the Study:

  • 89% of online European adults (154 million) use the Internet for health info in 2010.
  • 44% of online European adults use the Internet for pharmaceutical information.
  • Wikipedia is either the #1 or #2 website used for health information in the UK, Spain, Italy, France, and Germany.
  • Half of Europeans using the Internet for health information are interested in online patient education programs from pharmaceutical companies.

Key Questions Answered in Cybercitizen Health® Europe v10.0:

Mobile Device Adoption

  • Which kinds of mobile devices do consumers own and plan to purchase (including iPad, iPod Touch and various smartphone brands)?
  • How strong is adoption of apps on mobile devices vs. browser use, and which genres of apps garner the highest adoption?
  • Which barriers are limiting more advanced use of mobile device features?
  • How fast is use of mobile devices for health growing?
  • How interested are consumers in using pharma-sponsored mobile health apps?

Health Information Seeking Behavior

  • How strong is demand for prescription drug information online?
  • How localized is health information seeking behavior (U.S. vs. national)?
  • To what extent do consumers use U.S. based prescription drug websites?
  • How strong is adoption of pharma-sponsored condition websites?
  • What are consumer behaviors when selecting health-related search engine results?
  • To what degree does trust vs. relevance drive search engine result choices?

Social Media

  • To what degree do consumers alter their treatment decisions as a result of health related social media?
  • What need is health social media filling for European consumers?

E-Empowered European Consumers

  • What evidence is there that online health resources are impacting European consumers' health decisions or actions?
  • To what degree do European consumers believe online health resources are improving?

About Cybercitizen Health® Europe v10.0
Cybercitizen Health® Europe v10.0 was fielded online in Q3 2010 among 3,000 adults (age 18+) in France, Germany, Italy, Spain, and the United Kingdom.

For more information, please visit http://www.manhattanresearch.com/ccheu.

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a global pharmaceutical and healthcare market research and strategic advisory firm and conducts annual research studies covering eHealth trends among healthcare professionals and consumers. For more information, please visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.decisionresources.com.

Most Popular Now

Pfizer's elranatamab granted FDA Breakthrough Ther…

Pfizer Inc. (NYSE:PFE) announced its investigational cancer immunotherapy, elranatamab, received Breakthrough Therapy Designation from the U.S. Food and Drug Administrati...

Salvat Laboratories announces submission of New Dr…

Salvat Laboratories announced that it has submitted a New Drug Application (NDA) to the FDA for the approval of the first ocular corticosteroid formulated in a nanoemulsi...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

New insights on antibody responses to Omicron vari…

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research quest...

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...